Sulfasalazine for alopecia areata

Journal of the American Academy of Dermatology

Volumn 46, Issue 4, 2002, Pages 541-544

  Ellis, Charles N ^a   Brown, Margaret F ^a   Voorhees, John J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SALAZOSULFAPYRIDINE; TRIAMCINOLONE;

ADULT; ALOPECIA AREATA; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; GROWTH RATE; HAIR GROWTH; HAIR LOSS; HUMAN; IMMUNOMODULATION; PRIORITY JOURNAL; PSORIASIS; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036553572     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.119671     Document Type: Article

References (13)

1. Gilhar A, Shalaginov R, Assy B, Serafimovich S, Kalish RS. Alopecia areata is a T-lymphocyte mediated autoimmune disease: lesional human T-lymphocytes transfer alopecia areata to human skin grafts on SCID mice. J Invest Dermatol Symp Proc 1999;4:207-10.
2. Hoffman R. The potential role of cytokines and T cells in alopecia areata. J Invest Dermatol Symp Proc 1999;4:235-8.
3. de Andrade M, Jackow CM, Dahm N, Hordinsky M, Reveille JD, Duvic M. Alopecia areata in families: association with the HLA locus. J Invest Dermatol Symp Proc 1999;4:220-3.
4. Gupta AK, Ellis CN, Cooper KD, Nickoloff BJ, Ho VC, Chan LS, et al. Oral cyclosporine for the treatment of alopecia areata: a clinical and immunohistochemical analysis. J Am Acad Dermatol 1990;22:242-50.
5. Olsen EA. Hair disorders. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, et al, editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1999. p. 739.
6. Bachrach WH. Sulfasalazine: I, an historical perspective. Am J Gastroenterol 1998;83:487-93.
7. Box SA, Pullar T. Sulphasalazine in the treatment of rheumatoid arthritis. Br J Rheumatol 1997;36:382-6.
8. Gupta AK, Ellis CN, Siegel MT, Duell EA, Griffiths CEM, Hamilton TA, et al. Sulfasalazine improves psoriasis: a double-blind analysis. Arch Dermatol 1990;126:487-93.
9. Gupta AK, Grober JS, Hamilton TA, Ellis CN, Siegel MT, Voorhees JJ, et al. Sulfasalazine therapy for psoriatic arthritis: a double-blind, placebo controlled trial. J Rheumatol 1995;22:5:894-8.
10. Smedegard G, Bjork J. Sulphasalazine: mechanism of action in rheumatoid arthritis. Br Soc Rheumatol 1995;34s:7-15.
11. Rains CP, Noble S, Faulds D. Sulfasalazine: a review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis. Drug Evaluation 1995;49:137-56.
12. Das KM, Dubin R. Clinical pharmacokinetics of sulphasalazine. Clin Pharmacokinetics 1976;1:406-25.
13. Olsen E, Hordinsky M, McDonald-Hull S, Price V, Roberts J, Shapiro J, et al. Alopecia areata investigational assessment guidelines. J Am Acad Dermatol 1999;40:242-6.